Similar articles

• Rationales for vaccines against leprosy.

  Bloom BR. Bloom BR. Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):505-9. Int J Lepr Other Mycobact Dis. 1983. PMID: 6368414 Clinical Trial. No abstract available.
• South India immunoprophylaxis trial against leprosy: relevance of findings in the context of leprosy trends.

  Gupte MD. Gupte MD. Int J Lepr Other Mycobact Dis. 2001 Jun;69(2 Suppl):S10-3. Int J Lepr Other Mycobact Dis. 2001. PMID: 11757173 Clinical Trial. No abstract available.
• A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.

  Bretscher PA. Bretscher PA. Immunol Today. 1992 Sep;13(9):342-5. doi: 10.1016/0167-5699(92)90168-7. Immunol Today. 1992. PMID: 1466750 Review.
• Investigations related to the development of a leprosy vaccine.

  Convit J, Aranzazu N, Ulrich M, Zúñiga M, de Aragón ME, Alvarado J, Reyes O. Convit J, et al. Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):531-9. Int J Lepr Other Mycobact Dis. 1983. PMID: 6231259 No abstract available.
• Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.

  Gormus BJ, Meyers WM. Gormus BJ, et al. Expert Rev Vaccines. 2003 Dec;2(6):791-804. doi: 10.1586/14760584.2.6.791. Expert Rev Vaccines. 2003. PMID: 14711362 Review.